Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Semin Oncol. 2011 Oct;38(5):682–692. doi: 10.1053/j.seminoncol.2011.04.011

Figure 1.

Figure 1

Overall survival after decitabine failure in patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and the total population. (Adapted with permission from Jabbour, et. al.16).